ACON | Aclarion, Inc.

Healthcare | Health Information Services | USA | NASD

Index	-	P/E	-	EPS (ttm)	-1.02	Insider Own	2.40%	Shs Outstand	7.87M	Perf Week	61.90%
Market Cap	8.10M	Forward P/E	-	EPS next Y	-0.38	Insider Trans	25.19%	Shs Float	5.21M	Perf Month	20.00%
Income	-8.00M	PEG	-	EPS next Q	-	Inst Own	2.90%	Short Float / Ratio	1.98% / 0.05	Perf Quarter	42.56%
Sales	0.06M	P/S	133.99	EPS this Y	-72.50%	Inst Trans	186.89%	Short Interest	0.10M	Perf Half Y	32.40%
Book/sh	0.23	P/B	4.43	EPS next Y	-	ROA	-217.70%	Target Price	3.00	Perf Year	-20.00%
Cash/sh	0.19	P/C	5.40	EPS next 5Y	-	ROE	-	52W Range	0.38 - 2.37	Perf YTD	75.86%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-56.96%	Beta	-
Dividend %	-	Quick Ratio	1.40	Sales past 5Y	-	Gross Margin	-	52W Low	168.42%	ATR	0.16
Employees	7	Current Ratio	1.40	Sales Q/Q	88.00%	Oper. Margin	-	RSI (14)	62.80	Volatility	27.09% 13.38%
Optionable	No	Debt/Eq	0.00	EPS Q/Q	-	Profit Margin	-	Rel Volume	0.14	Prev Close	1.03
Shortable	Yes	LT Debt/Eq	0.00	Earnings	-	Payout	-	Avg Volume	1.98M	Price	1.02
Recom	2.00	SMA20	36.73%	SMA50	34.03%	SMA200	26.98%	Volume	274,514	Change	-0.97%

May-30-23 07:30AM	Aclarion Announces New Engagement with The London Clinic and London Spine Clinic (GlobeNewswire) +77.97%
May-23-23 07:30AM	Aclarions Key Opinion Leader Program Adds Ninth Surgeon Advisor With Addition of Dean Karahalios, MD (GlobeNewswire) -9.91%
07:00AM	Aclarion, Inc. Announces Delayed 10-Q Filing (GlobeNewswire)
May-19-23 07:30AM	Aclarion Announces Non-Convertible Debt Financing to Achieve Three Critical Catalysts (GlobeNewswire)
May-11-23 12:41PM	Aclarion providing less invasive solution to treat lo back pain through augmented intelligence (News Direct)
07:00AM	Loading…
May-02-23 07:00AM	Aclarion Appoints Nicholas Theodore, MD as Principal Investigator for CLARITY Post-Market Trial Evaluating Nociscan in the Diagnosis and Treatment of Chronic Low Back Pain (GlobeNewswire) -5.81%
Apr-28-23 11:20AM	Aclarion to Host Thought Leadership Symposium at SPINEWEEK 2023 (GlobeNewswire) -16.17%
Apr-24-23 07:00AM	Aclarion Announces Publication of 2YR Outcomes in Groundbreaking Clinical Trial (GlobeNewswire) +73.00%
Mar-07-23 09:19AM	Aclarion Announces Alpesh Patel MD MBA as a Key Opinion Leader Physician Advisor (GlobeNewswire)
Feb-16-23 07:00AM	Aclarion to Present at Third Annual Winter Wonderland - Best Ideas Virtual Investor Conference on February 21st - 24th, 2023 (ACCESSWIRE)
Feb-15-23 07:00AM	Aclarion Supports Thought Leadership at the 2nd Annual Sonntag Spine Symposium (GlobeNewswire) -6.04%
Feb-05-23 08:50AM	Insiders who bought stock earlier this year lose -US$213k as Aclarion, Inc. (NASDAQ:ACON) drops to US$4.7m (Simply Wall St.)
Jan-31-23 10:01AM	Gregory Basil MD to Join Aclarion as a Key Opinion Leader Surgeon Advisor (GlobeNewswire)
Jan-17-23 08:29AM	Aclarion Appoints George Frey MD as Seventh Key Opinion Leader Surgeon Advisor (GlobeNewswire) +8.04%
08:00AM	Aclarion to Present at the Jan 26th Virtual Investor Summit Microcap Event (Newsfile)
10:36AM	Loading…
Dec-22-22 10:36AM	Dr. Christopher Ames to Join Aclarion as a Key Opinion Leader Surgeon Advisor (GlobeNewswire) -8.80%
Dec-21-22 10:23AM	Aclarions Key Opinion Leader Program Adds Fifth Surgeon Advisor with Addition of Eric Potts, MD (GlobeNewswire)
Dec-19-22 08:33AM	Aclarion Adds to Growing Key Opinion Leader Program with Juan Uribe M.D. as a Surgeon Advisor (GlobeNewswire) -13.03%
Dec-01-22 09:41AM	Aclarion Adds to Strong Patent Portfolio with Notice of Allowance for New U.S. Patent Application Addressing Key Pain Indicator Biomarker (GlobeNewswire) +9.03%
Nov-16-22 05:12AM	Aclarion Third Quarter 2022 Earnings: Revenues Beat Expectations, EPS Lags (Simply Wall St.) -8.91%
Oct-25-22 07:00AM	Aclarion, Inc. Releases Updated Investor Presentation In Connection with Appearance at LD Micro Main Event XV (ACCESSWIRE) +8.96%
Oct-24-22 07:00AM	Dr. Sigurd Berven to join Aclarion as a Key Opinion Leader Surgeon Advisor (ACCESSWIRE)
Oct-12-22 07:00AM	Aclarion To Present at The LD Micro Main Event XV (Newsfile)
Oct-10-22 07:05AM	Aclarion Announces Participation at the NASS 37th Annual Meeting (ACCESSWIRE) +8.73%
Oct-03-22 07:03AM	John Keller M.D. to Join Aclarion as a Key Opinion Leader Surgeon Advisor (ACCESSWIRE) +9.91%
Sep-19-22 07:03AM	Nociscan Selected for Inclusion in Pivotal National Institutes of Health (NIH) Study for Low Back Pain (ACCESSWIRE) -8.93%
Aug-04-22 07:00AM	Aclarion, Inc. to Present at Investor Summit Group's Q3 Virtual Conference (Newsfile)
Jul-22-22 09:01AM	Quite a few insiders invested in Aclarion, Inc. (NASDAQ:ACON) last year which is positive news for shareholders (Simply Wall St.)
Jul-20-22 07:00AM	Aclarion Announces Start of Healthcare Economic Analysis Study to Evaluate Financial Impact of Nociscan (ACCESSWIRE)
Jun-22-22 07:00AM	Aclarion to Present 2-year Follow Up Data on Pivotal Clinical Trial Linking Nociscan to Better Surgical Outcomes for Discogenic Low Back Pain (ACCESSWIRE)
09:15PM	Loading…
Apr-26-22 09:15PM	Aclarion, Inc. Announces Closing of $9.4 Million Initial Public Offering (ACCESSWIRE)
Apr-21-22 07:45PM	Aclarion, Inc. Announces Listing on Nasdaq and Pricing of $9.4 Million Initial Public Offering (ACCESSWIRE)

Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. The company develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in Broomfield, Colorado.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Thramann Jeffrey John	Executive Chairman	Feb 16	Buy	1000.00	1	1,000	1	Feb 21 04:02 PM
Lorbiecki John Paul	Chief Financial Officer	Dec 29	Buy	0.45	22,404	10,000	22,404	Dec 29 06:27 PM
Ness Brent	Chief Executive Officer	Dec 29	Buy	0.54	16,211	8,807	19,500	Dec 29 07:57 PM
Ness Brent	Chief Executive Officer	Dec 28	Buy	0.42	2,289	961	3,289	Dec 29 07:57 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ACON | Aclarion, Inc.

Upgrade your FINVIZ experience